The DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.
Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
Open accessAbstract
Decades of research have disclosed a plethora of alterations in protein glycosylation that decisively impact in all stages of disease and ultimately contribute to more aggressive cell phenotypes. The biosynthesis of cancer-associated glycans and its reflection in the glycoproteome is driven by microenvironmental cues and these events act synergistically toward disease evolution. Such intricate crosstalk provides the molecular foundations for the activation of relevant oncogenic pathways and leads to functional alterations driving invasion and disease dissemination. However, it also provides an important source of relevant glyco(neo)epitopes holding tremendous potential for clinical intervention. Therefore, we highlight the transversal nature of glycans throughout the currently accepted cancer hallmarks, with emphasis on the crosstalk between glycans and the tumor microenvironment stromal components. Focus is also set on the pressing need to include glycans and glycoconjugates in comprehensive panomics models envisaging molecular-based precision medicine capable of improving patient care. We foresee that this may provide the necessary rationale for more comprehensive studies and molecular-based intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–290 of 290
Osuala, K. O., Sameni, M., Shah, S., Aggarwal, N., Simonait, M. L., Franco, O. E., Hong, Y., Hayward, S. W., Behbod, F., Mattingly, R. R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1576-3 · Cited by 103
New trends in guided nanotherapies for digestive cancers: A systematic review
Fernandes, E., Ferreira, J. A., Peixoto, A., Luís, L., Barroso, S., Sarmento, B. F. C. C., & Santos, L. L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.003 · Cited by 102
Self-citationRenkonen, J., Tynninen, O., Häyry, P., Paavonen, T., & Renkonen, R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64210-1 · Cited by 97
Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.
Yamamoto, H., Oviedo, A., Sweeley, C., SAITO, T., & Moskal, J. R. (2001) · PubMed · Cited by 95
Galectin Interactions with Extracellular Matrix and Effects on Cellular Function
He, J., & Baum, L. G. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)17017-2 · Cited by 94
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
Dufour, F., Rattier, T., Shirley, S., Picarda, G. G. A., Constantinescu, A. A., Morlé, A., Zakaria, A. B., Marcion, G., Causse, S., Szegezdi, É., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.150 · Cited by 94
Murugaesu, N., Iravani, M., van Weverwijk, A., Ívetic, A., Johnson, D. A., Antonopoulos, A., Fearns, A., Jamal‐Hanjani, M., Sims, D., Fenwick, K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0287 · Cited by 92
Vascular galectins: Regulators of tumor progression and targets for cancer therapy
Thijssen, V. L., Rabinovich, G. A., & Griffioen, A. W. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.07.003 · Cited by 89
Peixoto, A., Fernandes, E., Gaiteiro, C., Lima, L., Azevedo, R., Soares, J., Cotton, S., Parreira, B. S., Neves, M., Amaro, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11257 · Cited by 88
Self-citationBuraschi, S., Neill, T., Owens, R. T., Iniguez, L. A., Purkins, G., Vadigepalli, R., Evans, B. J., Schaefer, L., Peiper, S. C., Wang, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045559 · Cited by 87
Munkley, J., Oltean, S., Vodák, D., Wilson, B. T., Livermore, K., Zhou, Y., Star, E., Floros, V., Johannessen, B., Knight, B., et al. (2015) · OncoTarget · doi:10.18632/oncotarget.6024 · Cited by 84
Rebbaa, A., Yamamoto, H., SAITO, T., Meuillet, E. J., Kim, P., Kersey, D. S., Bremer, E. G., Taniguchi, N., & Moskal, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9275 · Cited by 84
Tsuboi, S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1411 · Cited by 84
Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
Coyle, K. M., Boudreau, J. E., & Marcato, P. (2017) · BioMed Research International · doi:10.1155/2017/9620870 · Cited by 83
Wu, Y., Liu, C., Huang, M.-J., Lai, H., Lee, P., Hu, R., & Huang, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0869 · Cited by 81
Niewiarowska, J., Brézillon, S., Sacewicz‐Hofman, I., Bednarek, R., Maquart, F., Malinowski, M., Wiktorska, M., Wegrowski, Y., & Cierniewski, C. S. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.06.011 · Cited by 81
Liu, S. D., Chalouni, C. M., Young, J. C., Junttila, T. T., Sliwkowski, M. X., & Lowe, J. B. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0125 · Cited by 80
Mammalian O-Mannosylation Pathway: Glycan Structures, Enzymes, and Protein Substrates
Praissman, J. L., & Wells, L. (2014) · Biochemistry · doi:10.1021/bi500153y · Cited by 80
Struwe, W. B., Agravat, S. B., Aoki-Kinoshita, K. F., Campbell, M. P., Costello, C. E., Dell, A., Feizi, T., Haslam, S. M., Karlsson, N. G., Khoo, K., et al. (2016) · Glycobiology · doi:10.1093/glycob/cww082 · Cited by 79
Reversibility of oncogene-induced cancer
Felsher, D. W. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.12.008 · Cited by 78
Ozaki, H., Matsuzaki, H., Ando, H., Kaji, H., Nakanishi, H., Ikehara, Y., & Narimatsu, H. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9445-1 · Cited by 78
Novel roles for O-linked glycans in protein folding
Vasudevan, D., & Haltiwanger, R. S. (2014) · Glycoconjugate Journal · doi:10.1007/s10719-014-9556-4 · Cited by 77
N-linked (N-) Glycoproteomics of Urimary Exosomes*
Saraswat, M., Joenväärä, S., Musante, L., Peltoniemi, H., Holthöfer, H., & Renkonen, R. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.040345 · Cited by 75
Cohen, M., Elkabets, M., Perlmutter, M., Porgador, A., Voronov, E., Apte, R. N., & Lichtenstein, R. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001635 · Cited by 75
Du, W. W., Yang, B. B., Shatseva, T., Yang, B. L., Deng, Z., Shan, S. W., Lee, D. Y., Seth, A. K., & Yee, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013828 · Cited by 73
Costa, C., Pereira, S., Lima, L., Peixoto, A., Fernandes, E., Neves, D., Neves, M., Gaiteiro, C., Tavares, A., da Costa, R. M. G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141253 · Cited by 73
Self-citationKroes, R. A., He, H., Emmett, M. R., Nilsson, C. L., Leach, F. E., Amster, I. J., Marshall, A. G., & Moskal, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909862107 · Cited by 72
Lee‐Sundlov, M. M., Ashline, D. J., Hanneman, A. J. S., Grozovsky, R., Reinhold, V. N., Hoffmeister, K. M., & Lau, J. T. Y. (2016) · Glycobiology · doi:10.1093/glycob/cww108 · Cited by 72
Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation
Shatnyeva, O., Kubarenko, A. V., Weber, C. E. M., Pappa, A., Schwartz‐Albiez, R., Weber, A. N. R., Krammer, P. H., & Lavrik, I. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019927 · Cited by 71
Carcinoma Cell Hyaluronan as a “Portable” Cancerized Prometastatic Microenvironment
Turley, E. A., Wood, D. K., & McCarthy, J. B. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3114 · Cited by 71
Zhong, J., Martinez, M. R., Sengupta, S., Lee, A., Wu, X., Chaerkady, R., Chatterjee, A., O’Meally, R. N., Cole, R. N., Pandey, A., et al. (2014) · PROTEOMICS · doi:10.1002/pmic.201400339 · Cited by 69
Bassagañas, S., Allende, H., Cobler, L., Ortiz, M., Llop, E., de Bolós, C., & Peracaula, R. (2015) · Cytokine · doi:10.1016/j.cyto.2015.04.006 · Cited by 68
Croci, D. O., Cerliani, J. P., Pinto, N. A., Morosi, L. G., & Rabinovich, G. A. (2014) · Glycobiology · doi:10.1093/glycob/cwu083 · Cited by 68
Cole, C. L., Rushton, G., Jayson, G. C., & Avizienyte, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534263 · Cited by 66
Abdel‐Aal, A. M., Lakshminarayanan, V., Thompson, P., Supekar, N. T., Bradley, J. M., Wolfert, M. A., Cohen, P. A., Gendler, S. J., & Boons, G. (2014) · ChemBioChem · doi:10.1002/cbic.201402077 · Cited by 66
Cotton, S., Azevedo, R., Gaiteiro, C., Ferreira, D., Lima, L., Peixoto, A., Fernandes, E., Neves, M., Neves, D., Amaro, T., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12035 · Cited by 66
Self-citationAndrlová, H., Mastroianni, J., Madl, J., Kern, J. S., Melchinger, W., Dierbach, H., Wernet, F., Follo, M., Technau‐Hafsi, K., Has, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17160 · Cited by 65
Hypoxic regulation of glycosylation via the N-acetylglucosamine cycle
Shirato, K., Nakajima, K., Korekane, H., Takamatsu, S., Gao, C., Angata, T., Ohtsubo, K., & Taniguchi, N. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-015fr · Cited by 64
Integration of the Transcriptome and Glycome for Identification of Glycan Cell Signatures
Bennun, S. V., Yarema, K. J., Betenbaugh, M. J., & Krambeck, F. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002813 · Cited by 62
Sialosyl‐Lex expression defines invasive and metastatic properties of bladder carcinoma
Numahata, K., Satoh, M., Handa, K., Saito, S., Οhyama, C., Ito, A., Takahashi, T., Hoshi, S., Orikasa, S., & Hakomori, S. (2002) · Cancer · doi:10.1002/cncr.10268 · Cited by 62
The role of O-linked GlcNAc modification on the glucose response of ChREBP
Sakiyama, H., Fujiwara, N., Noguchi, T., Eguchi, H., Yoshihara, D., Uyeda, K., & Suzuki, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.113 · Cited by 61
Regulation of Akt signaling byO-GlcNAc in euglycemia
Soesanto, Y., Luo, B., Jones, D., Taylor, R. P., Gabrielsen, J. S., Parker, G. J., & McClain, D. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90366.2008 · Cited by 59
Hisanaga, K., Onodera, H., & Kogure, K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00763.x · Cited by 58
dos Santos, S. N., Junqueira, M. D. S., Francisco, G., Vilanova, M., Magalhães, A., Dias‐Baruffi, M., Chammas, R. J., Harris, A. L., Reis, C. A., & Bernardes, E. S. (2016) · Oncotarget · doi:10.18632/oncotarget.13192 · Cited by 58
Yokoe, S., Takahashi, M., Asahi, M., Lee, S. H., Li, W., Osumi, D., Miyoshi, E., & Taniguchi, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3023 · Cited by 57
Cancer-associated fibroblasts induce cancer cell apoptosis that regulates invasion mode of tumours
Itoh, G., Chida, S., Yanagihara, K., Yashiro, M., Aiba, N., & Tanaka, M. (2017) · Oncogene · doi:10.1038/onc.2017.49 · Cited by 57
Lumican inhibits B16F1 melanoma cell lung metastasis.
Brézillon, S., Zeltz, C., Schneider, L., Terryn, C., Vuillermoz, B. S., Ramont, L., Perrau, C., Pluot, M., Diébold, M.-D., Radwańska, A., et al. (2009) · PubMed · Cited by 55
Role of angiogenesis in urothelial bladder carcinoma
Fus, Ł., & Górnicka, B. (2016) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2016.830 · Cited by 55
An essential role for decorin in bladder cancer invasiveness
Behi, M. E., Krumeich, S., Lodillinsky, C., Kamoun, A., Tibaldi, L., Sugano, G., de Reyniès, A., Chapeaublanc, E., Laplanche, A., Lebrét, T., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302655 · Cited by 54
The E2F-1 associated retinoblastoma-susceptibility gene product is modified by O-GlcNAc
Wells, L., Slawson, C. M., & Hart, G. W. (2010) · Amino Acids · doi:10.1007/s00726-010-0709-x · Cited by 54
Lima, L., Oliveira, D. S., Ferreira, J. A., Tavares, A., Cruz, R., Medeiros, R., & Santos, L. L. (2014) · British Journal of Urology · doi:10.1111/bju.12844 · Cited by 53
Self-citationTargeting the VEGF pathway in metastatic bladder cancer
Mazzola, C. R., & Chin, J. L. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1041588 · Cited by 51
Burdick, M. M., Henson, K. A., Delgadillo, L. F., Choi, Y. E., Goetz, D. J., Tees, D. F. J., & Benencia, F. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00103 · Cited by 51
Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
Niedworok, C., Roeck, K., Kretschmer, I., Freudenberger, T., Nagy, N., Szarvas, T., Dorp, F. V., Reis, H., Rubben, H., & Fischer, J. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080084 · Cited by 49
Lima, L., Neves, M., Oliveira, M. I., Diéguez, L., Freitas, R., Azevedo, R., Gaiteiro, C., Soares, J., Ferreira, D., Peixoto, A., et al. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.08.012 · Cited by 49
Self-citationKong, D., Chen, F., & Sima, N. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2745 · Cited by 46
Li, C., Yang, Z., Du, Y., Tang, H., Chen, J., Hu, D., & Fan, Z. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3397 · Cited by 45
Lima, L., Severino, P. F., Silva, M., Miranda, A., Tavares, A., Pereira, S., Fernandes, E., Cruz, R., Amaro, T., Reis, C. A., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.571 · Cited by 44
Self-citationGreville, G., McCann, A. H., Rudd, P. M., & Saldova, R. (2016) · Epigenetics · doi:10.1080/15592294.2016.1241932 · Cited by 44
Natoni, A., Smith, T. A., Keane, N., McEllistrim, C., Connolly, C., Jha, A., Andrulis, M., Ellert, E., Raab, M. S., Glavey, S. V., et al. (2017) · Leukemia · doi:10.1038/leu.2017.123 · Cited by 44
O-glycan regulation of apoptosis and proliferation in colorectal cancer cell lines
Patsos, G., Masselot, C. R., Klein, A., Hebbe-Viton, V., Martin, R. S., Masselot, D., Graessmann, M., Paraskeva, C., Gallagher, T. C., & Corfield, A. P. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351372 · Cited by 42
Guo, J., Li, X., Tan, Z., Lu, W. D., Yang, G., & Guan, F. (2014) · Molecules · doi:10.3390/molecules191220073 · Cited by 41
Pocheć, E., Lityń́ska, A., Bubka, M., Amoresano, A., & Casbarra, A. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.08.010 · Cited by 40
Cui, H., Wang, H., Wang, Y., Song, J., Tian, H., Xia, C., & Shen, Y. (2016) · Oncology Reports · doi:10.3892/or.2016.5180 · Cited by 40
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
Azevedo, R., Peixoto, A., Gaiteiro, C., Fernandes, E., Neves, M., Lima, L., Santos, L. L., & Ferreira, J. A. (2017) · Oncotarget · doi:10.18632/oncotarget.19433 · Cited by 39
Self-citationYeh, C., Hsu, I., Song, W., Chang, H., Miyamoto, H., Xiao, G., Li, L., & Yeh, S. (2015) · PubMed · Cited by 39
Willenberg, A., Saalbach, A., Simon, J. C., & Anderegg, U. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.325 · Cited by 38
Manzari, B., Kudlow, J. E., Fardin, P., Merello, E., Ottaviano, C., Puppo, M., Eva, A., & Varesio, L. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000106 · Cited by 37
Said, N. A., & Theodorescu, D. (2012) · OncoImmunology · doi:10.4161/onci.20594 · Cited by 37
O-GlcNAc modification affects the ATM-mediated DNA damage response
Miura, Y., Sakurai, Y., & Endo, T. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.06.013 · Cited by 36
Borentain, P., Carmona, S., Mathieu, S., Jouve, É., Battari, A. E., & Gerolami, R. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3006-x · Cited by 36
Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction
Filho, A. F. D. S., de Sena, W. L. B., de Lima, L. R. A., Carvalho, L. V. D. N., Pereira, M. C., Santos, L. G. S., Santos, R. V. C., Tavares, L. B., Pitta, M. G. D. R., & Rêgo, M. J. B. D. M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471912 · Cited by 36
Self-citationvan Wijk, X. M., Thijssen, V. L., Lawrence, R., van den Broek, S. A., Dona, M., Naidu, N., Oosterhof, A., van de Westerlo, E. M. A., Kusters, L. J. A., Khaled, Y., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb4004332 · Cited by 35
A Method to the Madness of N-Glycan Complexity?
Stanley, P. (2007) · Cell · doi:10.1016/j.cell.2007.03.022 · Cited by 34
Glycosylation regulates turnover of cyclooxygenase‐2
Sevigny, M. B., Li, C.-F., Alas, M., & Hughes‐Fulford, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.073 · Cited by 34
Hegele, A., Mecklenburg, V., Varga, Z., Olbert, P. J., Hofmann, R. W., & Barth, P. J. (2010) · PubMed · Cited by 33
Lewis antigens in normal and neoplastic urothelium.
Limas, C. J., & Lange, P. H. (1985) · PubMed · Cited by 33
Lee, H. C., Wondimu, A., Liu, Y., Ma, J. S. Y., Radoja, S., & Ladisch, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201256 · Cited by 32
Fang, W. B., Mafuvadze, B., Yao, M., Zou, A., Portsche, M., & Cheng, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135063 · Cited by 31
Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review
Azevedo, R., Ferreira, J. A., Peixoto, A., Neves, M., Sousa, N., Lima, Á., & Santos, L. L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.002 · Cited by 30
Self-citationCoelho, R., Marcos-Silva, L., Mendes, N. M., Pereira, D., Brito, C., Jacob, F., Steentoft, C., Mandel, U., Clausen, H., David, L., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072045 · Cited by 30
Incorporating VEGF-targeted therapy in advanced urothelial cancer
Narayanan, S., & Srinivas, S. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016667179 · Cited by 29
Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells
Liang, J., Gao, W., & Cai, L. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s140940 · Cited by 29
Lumican Exhibits Anti-Angiogenic Activity in a Context Specific Manner
Sharma, B., Ramus, M. D., Kirkwood, C. T., et al. (2013) · Cancer Microenvironment · doi:10.1007/s12307-013-0134-2 · Cited by 28
The role of intracellular protein O-glycosylation in cell adhesion and disease
Bektas, M., & Rubenstein, D. S. (2011) · Journal of Biomedical Research · doi:10.1016/s1674-8301(11)60031-6 · Cited by 26
Glycoproteomic and glycomic databases
Hızal, D. B., Wolozny, D., Colao, J., Jacobson, E. F., Tian, Y., Krag, S. S., Betenbaugh, M. J., & Zhang, H. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-15 · Cited by 24
Lima, L., Ferreira, J. A., Tavares, A., Oliveira, D. S., Morais, A., Videira, P. A., Medeiros, R., & Santos, L. L. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.05.009 · Cited by 20
Self-citationAmano, M. T. M. (2013) · Journal of Glycomics & Lipidomics · doi:10.4172/2153-0637.1000108 · Cited by 18
Fujii, Y., Yoshida, M., Chien, L.-J., Kihara, K., Kageyama, Y., Yasukochi, Y., & Oshima, H. (2000) · Urologia Internationalis · doi:10.1159/000030512 · Cited by 16
N- and O-Glycomics from Minor Amounts of Formalin-Fixed, Paraffin-Embedded Tissue Samples
Hinneburg, H., Schirmeister, F., Korać, P., & Kolarich, D. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6493-2_11 · Cited by 14
Cited by
Immune checkpoint signaling and cancer immunotherapy
He, X., & Xu, C. (2020) · Cell Research · doi:10.1038/s41422-020-0343-4 · Cited by 1,371
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 460
Insights into the role of sialylation in cancer progression and metastasis
Dobie, C., & Skropeta, D. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01126-7 · Cited by 348
Pathological implication of protein post-translational modifications in cancer
Pan, S., & Chen, R. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101097 · Cited by 263
Glycosylation in cancer: mechanisms, diagnostic markers, and therapeutic applications
Qusairy, Z., & Rada, M. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05303-1 · Cited by 16
Metadata
- Authors
- Peixoto, A., Relvas-Santos, M., Azevedo, R., Santos, L. L., & Ferreira, J. A.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-05-14
- Volume
- 9
- Pages
- 380-380
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2945867085
- Cited by
- 334
- References
- 290
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.